Welcome to our dedicated page for Bionoid Pharma news (Ticker: BINP), a resource for investors and traders seeking the latest updates and insights on Bionoid Pharma stock.
Bionoid Pharma Inc (BINP) is a healthcare company specializing in the development of products and technologies in the health and wellness sector. They offer a range of products that help alleviate pain, improve recovery time, and enhance overall physical well-being. Recently, the company signed a landmark exclusive license agreement with Global Alerts Corp for the distribution of the Universal Public Service Emergency Notification Cell Broadcasting System, aimed at revolutionizing global mass notifications for public safety.
Bionoid Pharma (OTC Pink: BINP) announced its intent to acquire AiMaverickIntel.com, a leading Audience Acquisition platform utilizing Artificial Intelligence (AI). This move follows the cancellation of a previous agreement to acquire Global Alerts Corp. BINP's CEO, Wayne Cockburn, highlighted this acquisition as a pivotal step in BINP's growth, aimed at boosting audience targeting and customer acquisition capabilities. The strategic shift from Global Alerts Corp. to AiMaverickIntel.com underscores BINP’s commitment to leveraging advanced technology for enhanced engagement strategies.
FAQ
What does Bionoid Pharma Inc specialize in?
What kind of products does Bionoid Pharma offer?
What recent partnership has Bionoid Pharma entered into?
What is the goal of the partnership with Global Alerts Corp?
